Start here: what a microbiome actually is
Your gut holds a dense community of bacteria that help digest fibre, make certain vitamins, train the immune system, and produce signalling molecules that reach the rest of the body. A healthy community tends to be diverse and rich in species that ferment fibre into short-chain fatty acids.
Dysbiosis is the word for that community shifting out of balance: diversity falls, helpful species thin out, and potential troublemakers gain ground. It is a description of a state, not a diagnosis with a single cause.
What the test reads
Two methods dominate. 16S sequencing reads a single marker gene to name the bacterial families present, which is cheaper and coarser. Shotgun sequencing reads all the genetic material, which costs more but resolves species and some of what they can do. Both turn a stool sample into a map of who lives in your gut and in what proportion.
Pooled analyses describe a consistent long COVID signature: lower diversity and depletion of short-chain-fatty-acid producers such as Faecalibacterium prausnitzii, with enrichment of potential pathobionts.1
moderatewell-foundedgroup-level pattern
What it can and cannot tell you
At the group level the pattern is robust enough that long COVID guts look different from recovered controls, down to shifts at the phylum, genus, and species level.2 That is a genuine scientific finding.
What it is not, yet, is actionable for an individual. There is no validated long COVID microbiome diagnosis, and no sequencing result that tells you which treatment will help. Direct-to-consumer kits in particular tend to translate a group pattern into confident personal advice the science does not support.
Why diversity is the headline
Across gut research, lower diversity tends to track with worse health, because a varied microbial community is more resilient to disturbance and produces a fuller range of helpful molecules than a depleted one. The long COVID signature is, at its core, a loss of that variety, paired with a specific thinning of the bacteria that ferment dietary fibre into short-chain fatty acids.
Those fibre-fermenters are not just names on a list. Their short-chain fatty acids feed the cells lining your gut, help calm inflammation, and feed into signalling that reaches well beyond the gut itself, including pathways tied to mood and cognition. Losing them changes what the whole community can do for the rest of your body, which is why the depletion is treated as biologically meaningful rather than incidental, even while its exact consequences in long COVID are still being worked out.
The probiotic question
The intuitive next step is to put back what is missing, but the evidence does not yet support a specific probiotic, dose, or regimen for long COVID. The gut community is dense, individual, and only partly understood, and a handful of swallowed species rarely reshapes it in a lasting way, because the residents already there shape who can take hold.
The better-supported lever is unglamorous: a varied, fibre-rich diet, which feeds the very fibre-fermenters the long COVID signature is short of. That is a reasonable thing to do on general health grounds regardless of whether you ever sequence your stool, and it sidesteps the marketing problem entirely. Spending on a tailored probiotic promised by a consumer report is buying more certainty than the science currently offers.
Reading a microbiome report honestly
If you do order sequencing, the most useful frame is that you are looking at a snapshot of an ecosystem, not receiving a diagnosis. A result showing low diversity is consistent with the long COVID literature and can be genuinely interesting, but it does not tell you what caused the shift, whether the shift is driving your symptoms, or what specific action would reverse it.
The gap between a real group-level pattern and confident individual advice is where consumer kits tend to overreach. The dysbiosis link is well-founded; the personalized treatment plan built on top of a single stool sample is not. Keeping those two things separate protects you from acting, sometimes expensively and restrictively, on certainty that the underlying science has not earned.
What to weigh
If you are considering a microbiome test, separate curiosity from clinical use. Reading your own ecology can be interesting, but a report that promises tailored probiotics or a precise diagnosis is selling more certainty than exists. The dysbiosis link is well-founded; the personalized guidance built on top of it is not.
What we don't know
Honest about the edges of the evidence. These are open questions, not settled answers.
- Whether the dysbiosis pattern is a cause of long COVID, a consequence of it, or a bystander that travels alongside it.
- Whether correcting the microbiome, by diet, probiotics, or transplant, changes long COVID symptoms.
- How stable the signature is over time and across different diets in the same person.
- Whether any sequencing result should change a clinical decision today.
- How much the gut pattern overlaps with the serotonin and gut-brain pathways implicated elsewhere in long COVID.
- Whether consumer-grade sequencing is even accurate enough to act on at the individual level.
What this means for you
If you order a microbiome report, read it as a snapshot of an ecosystem rather than a diagnosis. A finding of low diversity is consistent with the long COVID literature, but it does not hand you a treatment, and no one yet knows how to reliably reshape the community for benefit.
The lower-risk, evidence-aligned moves, a fibre-rich and varied diet, are reasonable regardless of what a test shows. Spend cautiously on anything that claims to translate your specific results into a precise plan.
References
Each reference links to the source on PubMed, PMC, or the publisher.